|
|
1.
|
Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. MedStar authors:
Year: 2022
Citation: - International Journal of Molecular Sciences. 23(4), 2022 Feb 20.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Alobaidi R, Carney B, Clark H, Dougherty R, Haribabu Y, Kuo LW, Rosenthal DS, Simbulan-Rosenthal CM, Sykora P, Vakili S
|
|
|
2.
|
Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. MedStar authors:
- Burman, Kenneth D
- Klubo-Gwiezdzinska, Joanna
- Wartofsky, Leonard
Citation: - Endocrine-Related Cancer. 19(3):447-56, 2012 Jun.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Bauer A, Burman KD, Costello J, Hoperia V, Jensen K, Klubo-Gwiezdzinska J, Patel A, Vasko V, Wartofsky L
|
